Search Results

Site Search

Inflammatory Bowel Disease - Mayo Clinic Laboratories

Inflammatory bowel disease (IBD) is typically classified as either Crohn's disease or ulcerative colitis based on clinical features, colonoscopy findings, histologic changes, and the anatomical distribution of disease. In some cases,...

Urologic cancer - Insights

Learn about how our testing for patients with renal, bladder, and prostate cancer identifies the cancer’s genetic traits and helps direct treatment.

Hematology - Insights

Find out how our comprehensive hematology test menu aids in diagnosis and treatment across a wide range of complex pediatric hematologic disorders.

Research - Insights

The exchange of medical knowledge is a founding principle of Mayo Clinic. William J. Mayo, M.D., said it best: “It is a great thing to make scientific discoveries of rare value, but it is even greater to be willing to share these...

Biologic Therapy Testing - Mayo Clinic Laboratories

To monitor for immunogenicity, our reflexive approach first measures the biologic concentration within a patient’s specimen. Then, if necessary, an additional test is performed to assess the presence of antibodies to a specific drug that...

Myeloproliferative neoplasms - Insights

Learn about our reflexive molecular testing protocols that are designed to guide proper utilization of myeloproliferative neoplasms.

Mayo Clinic Offers New Prostate Cancer Test from Beckman Coulter, Reduces Unnecessary Biopsies - Insights

The prostate health index or phi test reduces the need for prostate cancer biopsies by 30 percent.

An artificial intelligence-powered approach reveals novel features of tumor cell metastasis - Insights

In a recent study, Mayo Clinic researchers developed the first cellular DNA barcoding with a machine-learning approach to reveal previously unknown metastatic behavior of tumor cells. Researchers barcoded the DNA of millions of human...

Mass spectrometry-based assay detects viral antigens directly from clinical specimens - Insights

In a newly published study, a team from Mayo Clinic’s Advanced Diagnostics Laboratory has developed a mass spectrometry-based assay that’s able to detect COVID-19 (SARS-CoV-2) pathogens from human proteins with, remarkably, 98% sensitivity...

Mayo Clinic Classical Hematology Conference - Insights

This conference will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders. Combining the clinical and laboratory experience of Mayo Clinic faculty, we will...

Mayo Clinic Classical Hematology Conference - Insights

This conference will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders. Combining the clinical and laboratory experience of Mayo Clinic faculty, we will...

Mayo Clinic Classical Hematology Conference - Insights

This conference will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders. Combining the clinical and laboratory experience of Mayo Clinic faculty, we will...

Mayo Clinic Classical Hematology Conference - Insights

This conference will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders. Combining the clinical and laboratory experience of Mayo Clinic faculty, we will...

Mayo Clinic Classical Hematology Conference - Insights

This conference will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders. Combining the clinical and laboratory experience of Mayo Clinic faculty, we will...

Mayo Clinic Classical Hematology Conference - Insights

This conference will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders. Combining the clinical and laboratory experience of Mayo Clinic faculty, we will...

Mayo Clinic Classical Hematology Conference - Insights

This conference will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders. Combining the clinical and laboratory experience of Mayo Clinic faculty, we will...

Mayo Clinic Classical Hematology Conference - Insights

This conference will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders. Combining the clinical and laboratory experience of Mayo Clinic faculty, we will...

Mayo Clinic Classical Hematology Conference - Insights

This conference will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders. Combining the clinical and laboratory experience of Mayo Clinic faculty, we will...

Patient Information and Signature Forms - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

Patient Information and Signature Forms - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

Algorithms - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

MAYO AZ out of state testing approval updated.pdf

Out of State Testing 899 North Capitol Street NE | 2nd Fl, Washington, DC 20002 | P 202-724-8800 | F 202-724-8677 | dchealth.dc.gov Date: August 11, 2023 RE: Out of State Testing Approval HFD-OS35 MAYO CLINIC MOLECULAR DIAGNOSTICS AZ is...

Pathways Case Studies: August 2023 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for August include the following sub-specialties: Bone and Soft Tissue Pathology,...

Second-Tier Assay for MPS I Newborn Screening Shows Remarkable Reduction of False Positives - Insights

Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder that typically presents with progressive multisystem involvement in early childhood. This condition results from the deficiency of the enzyme, alpha-L-iduronidase (IDUA), which...

Next-generation sequencing - Insights

Browse our full menu of genetic testing, which provides the highest quality molecular assays available.

Mayo Clinic Labs @Work: Rehab Elkadri - Insights

Rehab Elkadri joined Mayo Clinic Laboratories in December 2021, relocating from the United Kingdom to the United Arab Emirates. As an international clinical specialty liaison in the Neurology division for the Middle East and North Africa...

Mayo Clinic Labs @Work: Ona Saras - Insights

As a clinical specialty representative, Ona Saras’ decade-long dedication to patient care and advocacy for cutting-edge testing at Mayo Clinic Laboratories has transformed lives across Northern California and Reno, Nevada. Through personal...

Mayo Clinic Labs @Work: Carrie Lahner - Insights

Carrie began her career at Mayo Clinic in 2006 as the associate director of the Eisenberg Genomics Education Program. In her current role as a genetic counselor, she employs her skills to educate on genetic test offerings and support MCL’s...

Mayo Clinic Labs @Work: Tim Brantner - Insights

Before he arrived at Mayo Clinic, Tim Brantner worked for a variety of organizations outside of health care. He joined Mayo Clinic Laboratories 14 years ago to help tell the labs’ story.

MCL @Work: Becca Johnson - Insights

Becca Johnson, a dedicated project manager, joined Mayo Clinic in 2014, driven by a desire to contribute to an organization making a global impact. With BioPharma Diagnostics, Becca oversees large projects, ensuring efficient sample...

Collaboration Paves the Way for Rapid Discovery in Autoimmune Neurology - Insights

Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer.

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

Pharmacogenomics - Insights

Including comprehensive panels and medication targeted assays, Mayo Clinic Laboratories pharmacogenomic testing focuses on clinically actionable genes and enables the detection of more alleles than other testing.

Malabsorption panel: Filling a gap in pediatric care - Insights

Mayo Clinic Laboratories is committed to innovation that provides the right test at the right time for the right patients. That effort always starts with identifying gaps in patient care. Filling those gaps sometimes involves not developing...

Improving outcomes through comprehensive controlled substance monitoring - Insights

Controlled substance testing options vary in the details they provide about patient drug use, painting an incomplete picture of usage patterns that can hinder accurate prescription monitoring and treatment outcomes. However, a new...

Viral Hepatitis Testing - Mayo Clinic Laboratories

At Mayo Clinic, we utilize an algorithmic approach to testing that takes the guesswork out of test ordering to focus on proper test utilization, saving your institution time and money.

gastric_malt_posttherapy_follow-up_algorithm.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 01/2022 B cells present but not diagnostic. Suspicious for lymphoma Few B cells present but not diagnostic. Favor reactive Diagnostic for MALT...

Whole exome sequencing for hereditary disorders - Insights

Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...

Vector-borne diseases - Insights

Browse our full menu of individual tests and panels that aid in the diagnosis of vector-borne diseases.

Hematology - Insights

A Mayo Clinic BioPharma Diagnostics engagement offers partners access to Mayo Clinic Laboratories’ robust library of hematology evaluations.

Improving diagnosis of rare congenital disorders - Insights

Experts at Mayo Clinic have developed a unique method of testing that combines new technology with novel bioinformatics to promptly detect a group of uncommon genetic conditions that are often difficult to identify.

Gastroenterology Testing - Mayo Clinic Laboratories

All in One Place. From screening to therapeutic management, we offer a comprehensive,one-stop solution for gastroenterlogy test ordering.

Group purchasing - Insights

Mayo Clinic Laboratories works closely with group purchasing organizations (GPOs) and purchasing groups (PGs) to provide clients access to our esoteric tests and services, delivering solutions that drive efficiency.

Commercial laboratories - Insights

Mayo Clinic Laboratories is a one stop laboratory solution for commercial laboratories, offering the industry’s most comprehensive test menu, 24/7 customer service support and streamlined logistics to help clients meet their business goals.